Werewolf Therapeutics (HOWL) Receivables (2022 - 2024)
Werewolf Therapeutics (HOWL) posted quarterly Receivables of -$464000.0 for Q4 2024, up 87.33% year-over-year from -$247696.7 in Q1 2024, and down 148.13% on a QoQ basis from $964000.0 in Q3 2024.
Werewolf Therapeutics (HOWL) Receivables (2022 - 2024) Analysis & Trends
Werewolf Therapeutics has reported Receivables for 3 years, with the latest figure at -$464000.0 in Q4 2024.
- Receivables for Q4 2024 came in at -$464000.0, up 87.33% year-over-year; the trailing twelve-month figure through Dec 2024 was -$464000.0 (up 87.33% YoY), and the FY2024 annual result was -$1.3 million, up 71.14% from the prior year.
- Receivables eased to -$464000.0 in Q4 2024, from $964000.0 in the prior quarter.
- Over five years, Receivables peaked at $11.0 million in Q4 2022 and troughed at -$3.7 million in Q4 2023.
- A 3-year average of $3.0 million and a median of $964000.0 in 2024 frame the typical range for Receivables.
- The widest annual swing landed in 2023, when Receivables plunged 133.2%; it then soared 87.33% in 2024.
- A 3-year view of Receivables shows it stood at $11.0 million in 2022, then slumped by 133.2% to -$3.7 million in 2023, then soared by 87.33% to -$464000.0 in 2024.
- Per Business Quant data, the three most recent Receivables figures were -$464000.0 in Q4 2024, $964000.0 in Q3 2024, and $845000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.93 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 160.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1.06 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 912.74 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.09 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 215.33 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Werewolf Therapeutics | 43.94 Mn | 43.94 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -464,000.00 |
| Sep 30, 2024 | 464,000.00 |
| Jun 30, 2024 | 845,000.00 |
| Mar 31, 2024 | 1.08 Mn |
| Dec 31, 2023 | -4.16 Mn |
| Sep 30, 2023 | 10.91 Mn |
| Dec 31, 2022 | 11.03 Mn |